Etsuko Miyamoto-Sato, a director of our company, was introduced in the Nihon Keizai Shimbun.

The article was titled “Research and Development of Pancreatic Cancer Therapeutics”, and was published as FuturedMe Co., Ltd., which was founded by Miyamoto, “breaks the common sense of drug discovery” with the new technology “CANDDY”.
Introducing Miyamoto, who was honored at the “Women’s Challenge Award”, which honors women who are active at the Council for Gender Equality of Women in the Cabinet Office this year, to take on the challenge of drug discovery with new technology.

For more information is here